Eton Pharmaceuticals, Inc. (ETON)Healthcare | Drug Manufacturers - Specialty & Generic | Deer Park, United States | NasdaqGM
37.34 USD
+0.73
(1.994%)
⇧
(July 13, 2026, 4 p.m.
EDT)
After hours: 37.34 |
Hot Take ↕ | July 11, 2026, 2:36 a.m. EDT
The immediate outlook is bullish, driven by a powerful technical rebound and aggressive speculative positioning. The stock has erased much of its prior weakness, trading well above its 200-day average, and options flow suggests a heavy bet on a move toward the $45 resistance zone. However, the long-term picture remains mixed due to the company's persistent losses and negative equity, which keep the valuation stretched despite the recent price surge. The lack of a dividend and the reliance on future growth to justify the current price create a high-risk profile suitable for momentum traders but less ideal for value investors seeking stability. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.084902 |
| MSTL | 0.091390 |
| AutoTheta | 0.132909 |
| AutoARIMA | 0.196955 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 35% |
| H-stat | 6.96 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.435 |
| Excess Kurtosis | -0.78 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 102.113 |
| Revenue per Share | 3.219 |
| Market Cap | 1,022,830,656 |
| Forward P/E | 19.86 |
| Beta | 0.86 |
| Profit Margins | -1.70% |
| Website | https://www.etonpharma.com |
As of July 11, 2026, 2:36 a.m. EDT: Speculators are aggressively positioning for a breakout above $45, evidenced by massive open interest in August 2026 calls at the $45 strike compared to negligible put volume. Conversely, traders are hedging downside risks below $30 with significant put open interest at the $30 strike for the near term, creating a 'long gamma' environment where the stock could gap up on earnings or catalysts while facing resistance at the $45 level.
| Attribute | Value |
|---|---|
| 52 Week Change | 1.5178816 |
| Address1 | 21,925 W. Field Parkway |
| Address2 | Suite 235 |
| All Time High | 38.62 |
| All Time Low | 1.95 |
| Ask | 45.13 |
| Ask Size | 2 |
| Audit Risk | 5 |
| Average Daily Volume10 Day | 485,420 |
| Average Daily Volume3 Month | 407,363 |
| Average Volume | 407,363 |
| Average Volume10Days | 485,420 |
| Beta | 0.861 |
| Bid | 26.51 |
| Bid Size | 2 |
| Board Risk | 8 |
| Book Value | 1.119 |
| City | Deer Park |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 8 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 37.34 |
| Current Ratio | 1.205 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 37.5 |
| Day Low | 35.0 |
| Debt To Equity | 102.113 |
| Display Name | Eton Pharmaceuticals |
| Earnings Call Timestamp End | 1,778,790,600 |
| Earnings Call Timestamp Start | 1,778,790,600 |
| Earnings Timestamp | 1,778,788,800 |
| Earnings Timestamp End | 1,786,046,400 |
| Earnings Timestamp Start | 1,786,046,400 |
| Ebitda | 11,085,000 |
| Ebitda Margins | 0.12751001 |
| Enterprise To Ebitda | 93.318 |
| Enterprise To Revenue | 11.899 |
| Enterprise Value | 1,034,431,616 |
| Eps Current Year | 1.01 |
| Eps Forward | 1.88 |
| Eps Trailing Twelve Months | -0.06 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 32.044 |
| Fifty Day Average Change | 5.2960014 |
| Fifty Day Average Change Percent | 0.1652728 |
| Fifty Two Week Change Percent | 151.78816 |
| Fifty Two Week High | 38.62 |
| Fifty Two Week High Change | -1.2799988 |
| Fifty Two Week High Change Percent | -0.03314342 |
| Fifty Two Week Low | 13.76 |
| Fifty Two Week Low Change | 23.58 |
| Fifty Two Week Low Change Percent | 1.7136627 |
| Fifty Two Week Range | 13.76 - 38.62 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,542,119,400,000 |
| Float Shares | 21,259,483 |
| Forward Eps | 1.88 |
| Forward P E | 19.861702 |
| Free Cashflow | 2,438,625 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 44 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,782,864,000 |
| Gross Margins | 0.59719 |
| Gross Profits | 51,916,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.044499997 |
| Held Percent Institutions | 0.65949 |
| Implied Shares Outstanding | 27,392,358 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Industry Disp | Drug Manufacturers - Specialty & Generic |
| Industry Key | drug-manufacturers-specialty-generic |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois. |
| Long Name | Eton Pharmaceuticals, Inc. |
| Market | us_market |
| Market Cap | 1,022,830,656 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_435353222 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -1,475,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,002,834,226 |
| Number Of Analyst Opinions | 3 |
| Open | 36.16 |
| Operating Cashflow | 15,839,000 |
| Operating Margins | 0.113900006 |
| Overall Risk | 8 |
| Payout Ratio | 0.0 |
| Phone | 847 787 7361 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 37.34 |
| Post Market Time | 1,783,981,117 |
| Previous Close | 36.61 |
| Price Eps Current Year | 36.9703 |
| Price Hint | 2 |
| Price To Book | 33.36908 |
| Price To Sales Trailing12 Months | 11.7656 |
| Profit Margins | -0.016970001 |
| Quick Ratio | 0.749 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.73 |
| Regular Market Change Percent | 1.99399 |
| Regular Market Day High | 37.5 |
| Regular Market Day Low | 35.0 |
| Regular Market Day Range | 35.0 - 37.5 |
| Regular Market Open | 36.16 |
| Regular Market Previous Close | 36.61 |
| Regular Market Price | 37.34 |
| Regular Market Time | 1,783,972,801 |
| Regular Market Volume | 265,254 |
| Return On Assets | 0.047620002 |
| Return On Equity | -0.05357 |
| Revenue Growth | 0.404 |
| Revenue Per Share | 3.219 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 8 |
| Shares Outstanding | 27,392,358 |
| Shares Percent Shares Out | 0.0529 |
| Shares Short | 1,449,499 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 1,261,144 |
| Short Name | Eton Pharmaceuticals, Inc. |
| Short Percent Of Float | 0.0744 |
| Short Ratio | 3.48 |
| Source Interval | 15 |
| State | IL |
| Symbol | ETON |
| Target High Price | 57.0 |
| Target Low Price | 40.0 |
| Target Mean Price | 45.66667 |
| Target Median Price | 40.0 |
| Total Cash | 19,661,000 |
| Total Cash Per Share | 0.718 |
| Total Debt | 31,262,000 |
| Total Revenue | 86,934,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.06 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 21.98195 |
| Two Hundred Day Average Change | 15.358049 |
| Two Hundred Day Average Change Percent | 0.69866633 |
| Type Disp | Equity |
| Volume | 265,254 |
| Website | https://www.etonpharma.com |
| Zip | 60,010-7278 |